Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Selective EP2-binding agents and their therapeutic use claimed by Ono

June 8, 2000

Vical's cationic lipid formulation selectively enhances antibody immune response to antigen pDNA

June 7, 2000

Intellivax and Active Biotech form partnership to develop streptococcal vaccine

June 7, 2000

Efforts to develop malaria vaccines reviewed at ECCMID; new candidate from SB highlighted

June 2, 2000

Repligen acquires U.S. patent rights to CTLA4-Ig

June 2, 2000

Neisseria outer membrane proteins useful for the therapy, diagnosis of infections

June 1, 2000

Immunosuppressive and antitumor properties of new histone deacetylase inhibitor WF-27082B

May 31, 2000

Enzo Biochem's tolerance induction therapy may be useful in GVHD

May 31, 2000

SciClone's Zadaxin now available in Italy

May 31, 2000

L-Glu-L-Trp analogues with advantages over parent compound

May 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...